ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $339,174 | -22.3% | 9,514 | +0.6% | 0.01% | -16.7% |
| Q2 2023 | $436,436 | +42.5% | 9,461 | +23.9% | 0.01% | +50.0% |
| Q1 2023 | $306,244 | -14.3% | 7,637 | -1.0% | 0.00% | -33.3% |
| Q4 2022 | $357,436 | +35.9% | 7,715 | +21.3% | 0.01% | +20.0% |
| Q3 2022 | $263,000 | -31.7% | 6,361 | -1.3% | 0.01% | -37.5% |
| Q2 2022 | $385,000 | -7.0% | 6,446 | +13.2% | 0.01% | +14.3% |
| Q1 2022 | $414,000 | -13.9% | 5,696 | -0.4% | 0.01% | -12.5% |
| Q4 2021 | $481,000 | -5.1% | 5,718 | +1.7% | 0.01% | -20.0% |
| Q3 2021 | $507,000 | -8.2% | 5,621 | -3.0% | 0.01% | 0.0% |
| Q2 2021 | $552,000 | +117.3% | 5,794 | +215.2% | 0.01% | +66.7% |
| Q4 2020 | $254,000 | +23.9% | 1,838 | -30.0% | 0.01% | +20.0% |
| Q2 2020 | $205,000 | – | 2,627 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |